Diagnostic accuracy study to determine performance of Cxbladder tests to indicate whether patients are at low or high risk of bladder cancer when presenting with blood in urine.

Pacific Edge Pty Ltd0 个研究点目标入组 500 人开始时间: 2018年1月17日最近更新: 2022年6月20日

适应症

试验速览

暂无简介。

•Patient is undergoing investigative cystoscopy for investigation of recent (within the last 3 months) macroscopic or microscopic haematuria
•- Patient must be able and willing to comply with study requirements – for Stage I and Stage II of the study.
•- Patients must be over 18 years of age.

•- Prior history of UC.
•- Prior genitourinary manipulation in the 14 days before urine collection.
•- Current or known history of urinary tract inflammatory disorder.
•- Recent history of glomerulonephritis, nephrosis or other renal inflammatory disorders.
•- Recent history of pyelonephritis.
•- Patient is presenting with confirmation of a current urinary tract infection.
•- Patient is presenting with confirmation of current bladder or large renal calculi (specifically large/obstructive/inflammatory renal calculi only – patients with small non-obstructive calculi are not to be excluded).
•- Prior history (past 12 months of an episode of macroscopic haematuria with confirmed diagnosis (malignant or otherwise).

发起方

Pacific Edge Pty Ltd